Giuseppe S. Alvaro
Oprichter bij Autifony Therapeutics Ltd.
Profiel
Giuseppe S.
Alvaro is the founder and the Chief Research Officer at Autifony Therapeutics Ltd., a company founded in 2011.
He previously worked as the Director & Chemistry Leader at GSK Plc.
Dr. Alvaro holds a doctorate degree from Alma Mater Studiorum - Università di Bologna.
Actieve functies van Giuseppe S. Alvaro
| Bedrijven | Functie | Begin |
|---|---|---|
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Oprichter | 24-08-2011 |
Eerdere bekende functies van Giuseppe S. Alvaro
| Bedrijven | Functie | Einde |
|---|---|---|
| GSK PLC | Directeur/Bestuurslid | - |
Opleiding van Giuseppe S. Alvaro
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
